ES2004038A6 - Nucleic acid derivatives having sulphur substitution - Google Patents

Nucleic acid derivatives having sulphur substitution

Info

Publication number
ES2004038A6
ES2004038A6 ES8700012A ES8700012A ES2004038A6 ES 2004038 A6 ES2004038 A6 ES 2004038A6 ES 8700012 A ES8700012 A ES 8700012A ES 8700012 A ES8700012 A ES 8700012A ES 2004038 A6 ES2004038 A6 ES 2004038A6
Authority
ES
Spain
Prior art keywords
sulphur
nucleic acid
substituted
acid derivatives
polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8700012A
Other languages
Spanish (es)
Inventor
Junichi Yano
Tadaaki Ohgi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of ES2004038A6 publication Critical patent/ES2004038A6/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The derivatives comprise nucleic acid polymers (e.g. single or double strand ribo or deoxyribo nucleotide polymers) in which some of the purine and/or pyrimidine rings are substituted with sulphur (e.g. by replacement of -NH2 groups by -SH groups), which sulphur substituents may be linked to form disulphide bonds. The sulphur substituted derivatives appear to more stable than non-substituted nucleic and polymers. The derivatives appear to act as immunostimulants and neoplastic proliferation inhibitors.
ES8700012A 1986-01-06 1987-01-05 Nucleic acid derivatives having sulphur substitution Expired ES2004038A6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP107686 1986-01-06

Publications (1)

Publication Number Publication Date
ES2004038A6 true ES2004038A6 (en) 1988-12-01

Family

ID=11491410

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8700012A Expired ES2004038A6 (en) 1986-01-06 1987-01-05 Nucleic acid derivatives having sulphur substitution

Country Status (11)

Country Link
JP (1) JPS62252798A (en)
KR (1) KR940004076B1 (en)
BE (1) BE906157A (en)
CA (1) CA1315717C (en)
CH (1) CH671960A5 (en)
DE (1) DE3700164A1 (en)
ES (1) ES2004038A6 (en)
FR (1) FR2596762B1 (en)
GB (1) GB2185026B (en)
NL (1) NL8700016A (en)
SE (1) SE469594B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100644172B1 (en) * 1998-05-25 2006-11-10 니뽄 신야쿠 가부시키가이샤 Process for producing composite preparation containing nucleic acid
EP1435389A4 (en) * 2001-09-04 2006-02-22 Nippon Shinyaku Co Ltd Method of evaluating efficacy of nucleic acid therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906851A (en) * 1960-05-03 1962-09-26 Schwarz Bio Res Inc Thiolation of polymers
DE2041735A1 (en) * 1970-08-22 1972-02-24 Merck Patent Gmbh Thio-pyrimidine derivatives
GB1364987A (en) * 1971-06-19 1974-08-29 Merck Patent Gmbh Biologically active two component complexes
GB2038628A (en) * 1978-11-14 1980-07-30 Searle & Co Physiological compositions comprising poly(4-thiouridylic acid) or copolymers thereof and the use thereof as anti-viral agents or serum cholesterol lowering agents

Also Published As

Publication number Publication date
NL8700016A (en) 1987-08-03
KR870007198A (en) 1987-08-17
CH671960A5 (en) 1989-10-13
GB2185026A (en) 1987-07-08
SE8605616D0 (en) 1986-12-30
KR940004076B1 (en) 1994-05-11
DE3700164C2 (en) 1993-02-25
FR2596762B1 (en) 1993-10-08
GB8700183D0 (en) 1987-02-11
DE3700164A1 (en) 1987-07-09
GB2185026B (en) 1990-08-08
JPS62252798A (en) 1987-11-04
SE469594B (en) 1993-08-02
CA1315717C (en) 1993-04-06
BE906157A (en) 1987-07-01
FR2596762A1 (en) 1987-10-09
SE8605616L (en) 1987-07-07

Similar Documents

Publication Publication Date Title
HU912253D0 (en) Process for the production of purinyl-phosphonic acid derivatives
EE05735B1 (en) Xanthin derivatives, their production and utilisation as medicine
MY110871A (en) Novel sulfonylamino pyrimidines
MY121294A (en) Novel hexanoic acid derivatives.
ATE286126T1 (en) GLIALMITOGENIC FACTORS, THEIR PRODUCTION AND USE
WO2004046148A8 (en) Novel xanthin derivatives, production and use thereof as medicaments
GR3024597T3 (en) 7-deazapurine modified oligonucleotides
DE59803845D1 (en) SULFINIC ACID DERIVATIVES AND THEIR PRODUCTION AND USE
MX9803954A (en) Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them.
MY110747A (en) Quinolone-and naphthyridonecarboxylic acid derivatives
YU47023B (en) PROCEDURE FOR THE PRODUCTION OF ISOMERIZED HOPS EXTRACT
BR9803727A (en) Biostable water-based paints and process for their preparations.
ES2132609T3 (en) ARILACETIC ACID DERIVATIVES AND THEIR USE AS FUNGICIDES.
ATE121097T1 (en) GRISEOLIC ACID DERIVATIVES, THEIR PRODUCTION AND THEIR USE.
ES2004038A6 (en) Nucleic acid derivatives having sulphur substitution
AU586808B2 (en) Purine derivatives
CO4770883A1 (en) PROCEDURE FOR PREPARING L-ASCORBIC ACID
IL138288A0 (en) Process for the production of purine derivatives and intermediates thereof
ES8701224A1 (en) Method for production of cytidine and/or deoxycytidine.
AU576107B2 (en) Isohexide-nucleoside
ES2097023T3 (en) DERIVATIVES OF SUCCINOYLAMINO-HYDROXYETHYLAMINE-SULPHAMIC ACID USEFUL AS RETROVIRAL PROTEASE INHIBITORS.
IT1205699B (en) New nucleic acid derivs. having sulphur substits.
CA2354025A1 (en) Modification of interferon alpha production
DK0611373T3 (en) Oligo-2-desoxynucleotides and their use as antiviral drugs.
ATE168683T1 (en) SUBSTITUTED IMINOACETONITRILES WITH MYOCARDIOPROTECTIVE EFFECT

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980401